| Literature DB >> 33357424 |
Fabio Desideri1, Andrea Cipriano1, Silvia Petrezselyova2, Giulia Buonaiuto1, Tiziana Santini3, Petr Kasparek2, Jan Prochazka2, Giacomo Janson4, Alessandro Paiardini4, Alessandro Calicchio1, Alessio Colantoni3, Radislav Sedlacek2, Irene Bozzoni5, Monica Ballarino6.
Abstract
Chromatin architect of muscle expression (Charme) is a muscle-restricted long noncoding RNA (lncRNA) that plays an important role in myogenesis. Earlier evidence indicates that the nuclear Charme isoform, named pCharme, acts on the chromatin by assisting the formation of chromatin domains where myogenic transcription occurs. By combining RNA antisense purification (RAP) with mass spectrometry and loss-of-function analyses, we have now identified the proteins that assist these chromatin activities. These proteins-which include a sub-set of splicing regulators, principally PTBP1 and the multifunctional RNA/DNA binding protein MATR3-bind to sequences located within the alternatively spliced intron-1 to form nuclear aggregates. Consistent with the functional importance of pCharme interactome in vivo, a targeted deletion of the intron-1 by a CRISPR-Cas9 approach in mouse causes the release of pCharme from the chromatin and results in cardiac defects similar to what was observed upon knockout of the full-length transcript.Entities:
Keywords: CRISPR Cas9; alternative splicing; chromatin; epigenetic control; introns; lncRNA; muscle; myogenesis; nuclear aggregates; ribonucleoparticle
Mesh:
Substances:
Year: 2020 PMID: 33357424 PMCID: PMC7773549 DOI: 10.1016/j.celrep.2020.108548
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423